Showing items related by title and subject

• 

  Web annex G: safety and efficacy of antiretroviral drugs for post-exposure prophylaxis: updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 

  World Health Organization; Shubber, Z.; Ford, N. (‎World Health Organization, 2018)‎
• 

  Web annex H: indeterminate results during HIV early infant diagnosis testing: a meta-analysis and review of the literature: updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 

  World Health Organization; Luo, R.; Boeras, D.; Broyles, L.; Vojnov, L. (‎World Health Organization, 2018)‎
• 

  Web annex C: safety of dolutegravir in pregnancy and breastfeeding: updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 

  World Health Organization; Mofenson, L. (‎World Health Organization, 2018)‎